http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0338b6000c6f93c74d940f5bca5a9cc
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Melisi |
| name | Davide Melisi |
| given-name | Davide |
| organization-name | Authors' Affiliations: Departments of 1Gastrointestinal Medical Oncology, 2Surgical Oncology, 3Molecular and Cellular Oncology, and 4Anesthesiology and Pain Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 5Bipar Sciences, Inc., South San Francisco, California 1Digestive Molecular Clinical Oncology Research Unit, Department of Medicine, Università degli studi di Verona, Verona, Italy.; 3Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy. 6Digestive Molecular Clinical Oncology Research Unit, Università degli studi di Verona, Verona, Italy. Medical Oncology, University of Verona, Verona, Italy 3Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Dipartimento di Scienze Biomorfologiche e Funzionali, Università di Napoli “Federico II,” Napoli, Italy; and 2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Università degli Studi di Napoli Federico II, Naples, Italy Digestive Molecular Clinical Oncology Research Unit, Section of Medical Oncology, Department of Medicine, University of Verona, Verona, Italy 1Departments of Gastrointestinal Medical Oncology, 2Surgical Oncology, and 3Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center; 4Cancer Biology Program, The University of Texas at Houston Graduate School of Biomedical Sciences, Houston, Texas Department of Medicine, University of Verona-AOUI Verona, Verona, Italy. Authors' Affiliations: 1Experimental Pharmacology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori–Fondazione “G. Pascale”, Naples, Italy; Departments of 2Molecular and Cellular Oncology and 3Gastrointestinal Medical Oncology/Digestive Diseases, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Experimental Pharmacology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori–Fondazione “G. Pascale”, Naples, Italy; Departments of 2Molecular and Cellular Oncology and 3Gastrointestinal Medical Oncology/Digestive Diseases, The University of Texas MD Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1Dipartmento di Endocrinologia ed Oncologia Molecolare e Clinica, Università di Napoli “Federico II”; 2Unità di Farmacologia Sperimentale, Istituto Nazionale per lo Studio e la Cura dei Tumori-Fondazione “G. Pascale,” Naples, Italy; Departments of 3Surgical Oncology and 4Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 5Oncologia Medica, 6Dipartimento di Patologia e Diagnostica, Università di Verona; 7ARC-NET, Center for Applied Research in Cancer, Verona, Italy; 8Idera Pharmaceuticals, Cambridge, Massachusetts; 9Institute for Cancer Research and Treatment, Università di Torino, Torino; and 10FIRC Institute of Molecular Oncology, Milan, Italy; Authors' Affiliations: 1Dipartmento di Endocrinologia ed Oncologia Molecolare e Clinica, Università di Napoli “Federico II”; 2Unità di Farmacologia Sperimentale, Istituto Nazionale per lo Studio e la Cura dei Tumori-Fondazione “G. Pascale,” Naples, Italy; Departments of 3Surgical Oncology and 4Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 5Oncologia Medica, 6Dipartimento di Patologia e Diagnostica, Università di Verona; 7ARC-NET, Center for Applied Research in Cancer, Verona, Italy; 8Idera Pharmaceuticals, Cambridge, Massachusetts; 9Institute for Cancer Research and Treatment, Università di Torino, Torino; and 10FIRC Institute of Molecular Oncology, Milan, Italy 1Department of Gastrointestinal Medical Oncology and Digestive Molecular Clinical Oncology Unit, Univeristy of Verona, 37134 Verona, Italy. 4Comprehensive Cancer Center, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.; 25Digestive Molecular Clinical Oncology Research Unit, Department of Medicine, Università degli Studi di Verona, Verona, Italy. Unit of Medical Oncology, University of Verona, 37126 Verona, Italy 1Digestive Molecular Clinical Oncology Research Unit, Department of Medicine, Università degli studi di Verona, Verona, Italy.; 8Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy. 1Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Università di Napoli Federico II; Cattedra di Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale “F Magrassi e A Lanzara,” Seconda Università di Napoli; Digestive Molecular Clinical Oncology Research Unit, Università degli studi di Verona, Verona, Italy; Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy; Pancreas Institute, Azienda Ospedaliera Universitaria Integrata, Verona, Italy Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy; Unit of Medical Oncology, Department of Surgery and Oncology, University of Verona Hospital Trust, Verona, Italy Investigational Cancer Therapeutics Clinical Unit, Azienda Ospedaliera Universitaria Integrata, P.le L. A. Scuro 10, 37134 Verona, Italy; Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, P.le L. A. Scuro 10, 37134 Verona, Italy. Department of Medicine, University of Verona, Verona, Italy Department of Medical Oncology, University and Hospital Trust of Verona, Verona, Italy 1Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Università di Napoli Federico II; Digestive Molecular Clinical Oncology Research Unit Università degli Studi di Verona Verona Italy; Investigational Cancer Therapeutics Clinical Unit Azienda Ospedaliera Universitaria Integrata Verona Italy Digestive Molecular Clinical Oncology Research Unit, Department of Medicine, Università degli studi di Verona, Verona, Italy davide.melisi@univr.it. |
Incoming Links
Total number of triples: 116.